Alhemo 15 mg/1.5 ml
Alhemo 15 mg/1.5 ml is a medicine authorised by Swissmedic under authorisation number 68844. The authorisation holder is Novo Nordisk Pharma AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 08 August 2023 and the authorisation is limited until 07 August 2028. ATC code B02BX places the medicine in the group Antihemorrhagics.
| Authorisation number | 68844 |
|---|---|
| Name | Alhemo 15 mg/1.5 ml |
| Full name | Alhemo 15 mg/1.5 ml, Injektionslösung im Fertigpen |
| Authorisation holder | Novo Nordisk Pharma AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | B02BX |
| First authorisation | 08 August 2023 |
| Authorisation validity | 07 August 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Alhemo 15 mg/1.5 ml, Injektionslösung im Fertigpen | A | 08 August 2023 |
| 2 | Alhemo 60 mg/1.5 ml, Injektionslösung im Fertigpen | A | 08 August 2023 |
| 3 | Alhemo 150 mg/1.5 ml, Injektionslösung im Fertigpen | A | 08 August 2023 |
| 4 | Alhemo 300 mg/3 ml, Injektionslösung im Fertigpen | A | 08 August 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigpen | B02BX | 06.01.1. | A |
| 2 | 1 | Fertigpen | B02BX | 06.01.1. | A |
| 3 | 1 | Fertigpen | B02BX | 06.01.1. | A |
| 4 | 1 | Fertigpen | B02BX | 06.01.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Alhemo 15 mg/1.5 ml authorised in Switzerland?
Yes. Alhemo 15 mg/1.5 ml is authorised by Swissmedic under authorisation number 68844, data as of 01 September 2026. The authorisation is limited until 07 August 2028.
Which dispensing category does Alhemo 15 mg/1.5 ml have?
Alhemo 15 mg/1.5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Alhemo 15 mg/1.5 ml?
The authorisation holder is Novo Nordisk Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.